NTRA:NASDAQ
Natera Inc
$399.42
arrow_upward
+1.52%(+5.98) 1D
$399.42
0.00% (0.00)
bedtimeAfter hours
Closed: Oct 19, 4:00:01 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for NTRA...
Open
$401.47
High
$408.20
Low
$397.20
Mkt. cap
57.57B
Avg. vol.
1.67M
Volume
1.33M
52-wk high
$437.41
52-wk low
$181.00
EPS
-$1.37
Beta
1.50
Shares outstanding
144.14M
No. of employees
6K
Open
$401.47
High
$408.20
Low
$397.20
Mkt. cap
57.57B
Avg. vol.
1.67M
Volume
1.33M
52-wk high
$437.41
52-wk low
$181.00
EPS
-$1.37
Beta
1.50
Shares outstanding
144.14M
No. of employees
6K
News stories
From web sources and news partners
TradingView
·
6 hours ago
Why Natera (NTRA) Stock Is Up Today
ad-hoc-news.de
·
9 hours ago
Natera stock: At EUR 359.70, Natera stock rises 3.24 percent versus Xetra close
ad-hoc-news.de
·
15 hours ago
JPMorgan raises Natera target to USD 460 for Natera stock
ad-hoc-news.de
·
18 hours ago
Natera to present 20 ESMO abstracts: stock pre-market at EUR 352.20
Profile
Natera, Inc. is a clinical genetic testing company based in Austin, Texas that specializes in non-invasive, cell-free DNA testing technology, with a focus on women's health, cancer, and organ health. Natera's proprietary technology combines novel molecular biology techniques with a suite of bioinformatics software that allows detection down to a single molecule in a tube of blood. Natera operates CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments in San Carlos, California and Austin, Texas. Wikipedia
About Natera Inc
CEOSteven Chapman
Employees6.14K
FoundedJan 1, 2004
HeadquartersAustin, Texas, United States
SectorBiotechnology
Websitenatera.com